In situ NIR spectroscopy monitoring of plasmid production processes effect of producing strain, medium composition and the cultivation strategy

BACKGROUND While the pharmaceutical industry keeps an eye on plasmid DNA production for new generation gene therapies, real-time monitoring techniques for plasmid bioproduction are as yet unavailable. This work shows the possibility of in situ monitoring of plasmid production in Escherichia coli cultures using a near infrared (NIR) fiber optic probe. RESULTS Partial least squares (PLS) regression models based on the NIR spectra were developed for predicting bioprocess critical variables such as the concentrations of biomass, plasmid, carbon sources (glucose and glycerol) and acetate. In order to achieve robust models able to predict the performance of plasmid production processes, independently of the composition of the cultivation medium, cultivation strategy (batch versus fed-batch) and E. coli strain used, three strategies were adopted, using: (i) E. coli DH5α cultures conducted under different media compositions and culture strategies (batch and fed-batch); (ii) engineered E. coli strains, MG1655ΔendAΔrecAΔpgi and MG1655ΔendAΔrecA, grown on the same medium and culture strategy; (iii) diverse E. coli strains, over batch and fed-batch cultivations and using different media compositions. PLS models showed high accuracy for predicting all variables in the three groups of cultures. CONCLUSION NIR spectroscopy combined with PLS modeling provides a fast, inexpensive and contamination-free technique to accurately monitoring plasmid bioprocesses in real time, independently of the medium composition, cultivation strategy and the E. coli strain used. © 2014 Society of Chemical Industry

[1]  G W Luli,et al.  Comparison of growth, acetate production, and acetate inhibition of Escherichia coli strains in batch and fed-batch fermentations , 1990, Applied and environmental microbiology.

[2]  M. Marquet,et al.  High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. , 1996, Human gene therapy.

[3]  W. Chen,et al.  Automated fed-batch fermentation with feed-back controls based on dissolved oxygen (DO) and pH for production of DNA vaccines , 1997, Journal of Industrial Microbiology and Biotechnology.

[4]  Anders Hagman,et al.  The use of NIR spectroscopy in monitoring and controlling bioprocesses , 1998 .

[5]  Brian McNeil,et al.  Fundamental investigations on the near-infrared spectra of microbial biomass as applicable to bioprocess monitoring , 1999 .

[6]  Grzegorz Węgrzyn,et al.  Medium design for plasmid DNA production based on stoichiometric model , 2001 .

[7]  S. Arnold,et al.  Use of at‐line and in‐situ near‐infrared spectroscopy to monitor biomass in an industrial fed‐batch Escherichia coli process , 2002, Biotechnology and bioengineering.

[8]  Carl-Fredrik Mandenius,et al.  Online monitoring of a bioprocess based on a multi‐analyser system and multivariate statistical process modelling , 2002 .

[9]  Diego Matteuzzi,et al.  Assessment of In‐Line Near‐Infrared Spectroscopy for Continuous Monitoring of Fermentation Processes , 2003, Biotechnology progress.

[10]  Brian McNeil,et al.  In‐situ near infrared spectroscopy to monitor key analytes in mammalian cell cultivation , 2003, Biotechnology and bioengineering.

[11]  E. Tamburini,et al.  Near-Infrared Spectroscopy: A Tool for Monitoring Submerged Fermentation Processes Using an Immersion Optical-Fiber Probe , 2003, Applied spectroscopy.

[12]  Eli Keshavarz-Moore,et al.  Effects of fermentation strategy on the characteristics of plasmid DNA production , 2003, Biotechnology and applied biochemistry.

[13]  Carl-Fredrik Mandenius,et al.  On-line multisensor monitoring of yogurt and filmjölk fermentations on production scale. , 2004, Journal of agricultural and food chemistry.

[14]  Carl-Fredrik Mandenius,et al.  On-line multi-analyzer monitoring of biomass, glucose and acetate for growth rate control of a Vibrio cholerae fed-batch cultivation. , 2005, Journal of biotechnology.

[15]  K. Bayer,et al.  Fast Quantification of Recombinant Protein Inclusion Bodies within Intact Cells by FT‐IR Spectroscopy , 2008, Biotechnology progress.

[16]  Feng-Sheng Wang,et al.  On-line estimation of biomass and intracellular protein for recombinant Escherichia coli cultivated in batch and fed-batch modes , 2007 .

[17]  R. Freitag,et al.  Strategies for high titre plasmid DNA production in Escherichia coli DH5α , 2007 .

[18]  James A. Williams,et al.  Generic plasmid DNA production platform incorporating low metabolic burden seed‐stock and fed‐batch fermentation processes , 2009, Biotechnology and bioengineering.

[19]  Nanna Petersen,et al.  In situ near infrared spectroscopy for analyte‐specific monitoring of glucose and ammonium in streptomyces coelicolor fermentations , 2010, Biotechnology progress.

[20]  J. Queiroz,et al.  Plasmid DNA fermentation strategies: influence on plasmid stability and cell physiology , 2011, Applied Microbiology and Biotechnology.

[21]  V. V. Lopes,et al.  High‐throughput analysis of the plasmid bioproduction process in Escherichia coli by FTIR spectroscopy , 2012, Biotechnology and bioengineering.

[22]  K. Prather,et al.  Development of new plasmid DNA vaccine vectors with R1-based replicons , 2012, Microbial Cell Factories.

[23]  K. Prather,et al.  De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production , 2012, Applied Microbiology and Biotechnology.

[24]  G. Monteiro,et al.  Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing , 2011, Biotechnology journal.

[25]  H. Büning Gene therapy enters the pharma market: The short story of a long journey , 2013, EMBO molecular medicine.